Literature DB >> 9683091

Using the person trade-off approach to examine differences between individual and social values.

P Dolan1, C Green.   

Abstract

Health state valuations, elicited by methods such as the standard gamble and the time trade-off, give an indication of the value that an individual attaches to particular health states. As measures of individual values, it has been argued that such valuations serve as poor proxies for social preferences, which, it is suggested, are a function of other factors, such as the initial severity of the patient's health state. The person trade-off (PTO) method has been proposed as a technique which takes account of many of these other factors. This paper reports on a study using the PTO to investigate whether an individual's preferences over treatments for themselves differ from their preferences when they are asked to think about the treatment of other people. The results suggest that there is indeed a difference, although qualitative data suggests that health gain is an important determinant of social value. This latter finding runs counter to those of a number of other studies which suggest that concerns about pre-treatment severity are as, if not more, important. Possible explanations for the differences are put forward.

Entities:  

Mesh:

Year:  1998        PMID: 9683091     DOI: 10.1002/(sici)1099-1050(199806)7:4<307::aid-hec345>3.0.co;2-n

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  12 in total

1.  Severity as an independent determinant of the social value of a health service.

Authors:  Jeff R J Richardson; John McKie; Stuart J Peacock; Angelo Iezzi
Journal:  Eur J Health Econ       Date:  2010-05-09

Review 2.  Resource allocation, social values and the QALY: a review of the debate and empirical evidence.

Authors:  David L B Schwappach
Journal:  Health Expect       Date:  2002-09       Impact factor: 3.377

Review 3.  Willingness to pay for a QALY: theoretical and methodological issues.

Authors:  Dorte Gyrd-Hansen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  To fund or not to fund: development of a decision-making framework for the coverage of new health technologies.

Authors:  Tania Stafinski; Devidas Menon; Christopher McCabe; Donald J Philippon
Journal:  Pharmacoeconomics       Date:  2011-09       Impact factor: 4.981

5.  Measuring the end-of-life premium in cancer using individual ex ante willingness to pay.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2017-08-12

6.  Transforming EQ-5D utilities for use in cost–value analysis of health programs.

Authors:  Erik Nord; Rune Johansen
Journal:  Eur J Health Econ       Date:  2015-04

7.  When are person tradeoffs valid?

Authors:  Jason N Doctor; John Miyamoto; Han Bleichrodt
Journal:  J Health Econ       Date:  2009-06-25       Impact factor: 3.883

8.  The social value of a QALY: raising the bar or barring the raise?

Authors:  Cam Donaldson; Rachel Baker; Helen Mason; Michael Jones-Lee; Emily Lancsar; John Wildman; Ian Bateman; Graham Loomes; Angela Robinson; Robert Sugden; Jose Luis Pinto Prades; Mandy Ryan; Phil Shackley; Richard Smith
Journal:  BMC Health Serv Res       Date:  2011-01-11       Impact factor: 2.655

9.  An Examination of Consistency in the Incremental Approach to Willingness to Pay: Evidence Using Societal Values for NHS Dental Services.

Authors:  Katherine Carr; Cam Donaldson; John Wildman; Robert Smith; Christopher R Vernazza
Journal:  Med Decis Making       Date:  2021-03-18       Impact factor: 2.583

10.  Societal preferences for standard health insurance coverage in the Netherlands: a cross-sectional study.

Authors:  Ineke van der Wulp; Wilbert B van den Hout; Marieke de Vries; Anne M Stiggelbout; Elske M van den Akker-van Marle
Journal:  BMJ Open       Date:  2012-04-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.